Carlson Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$505K Buy
3,494
+55
+2% +$8.52K 0.02% 76
2024
Q3
$557K Sell
3,439
-90
-3% -$14.3K 0.02% 74
2024
Q2
$516K Buy
3,529
+217
+7% +$32.3K 0.02% 75
2024
Q1
$524K Sell
3,312
-12,422
-79% -$1.98M 0.02% 71
2023
Q4
$2.47M Buy
15,734
+1,822
+13% +$279K 0.13% 49
2023
Q3
$2.17M Buy
13,912
+187
+1% +$30.9K 0.13% 49
2023
Q2
$2.27M Sell
13,725
-2,363
-15% -$381K 0.14% 47
2023
Q1
$2.49M Sell
16,088
-176
-1% -$28.4K 0.16% 43
2022
Q4
$2.87M Buy
16,264
+31
+0.2% +$5.35K 0.21% 39
2022
Q3
$2.65M Buy
16,233
+150
+0.9% +$25.4K 0.23% 39
2022
Q2
$2.85M Sell
16,083
-229
-1% -$40.8K 0.25% 35
2022
Q1
$2.89M Buy
16,312
+66
+0.4% +$11.2K 0.24% 36
2021
Q4
$2.78M Buy
16,246
+566
+4% +$92.7K 0.24% 36
2021
Q3
$2.53M Buy
15,680
+1,646
+12% +$281K 0.27% 32
2021
Q2
$2.31M Buy
14,034
+119
+0.9% +$19.7K 0.33% 30
2021
Q1
$2.29M Sell
13,915
-298
-2% -$48.2K 0.39% 26
2020
Q4
$2.27M Buy
14,213
+1,950
+16% +$288K 0.42% 24
2020
Q3
$1.83M Sell
12,263
-540
-4% -$79.9K 0.4% 23
2020
Q2
$1.82M Buy
12,803
+1,258
+11% +$183K 0.41% 22
2020
Q1
$1.79M Buy
11,545
+1,131
+11% +$160K 0.46% 21
2019
Q4
$1.52M Buy
10,414
+368
+4% +$49.9K 0.32% 24
2019
Q3
$1.3M Buy
10,046
+396
+4% +$52.2K 0.31% 25
2019
Q2
$1.34M Sell
9,650
-61
-0.6% -$8.44K 0.33% 25
2019
Q1
$1.36M Buy
9,711
+609
+7% +$81.6K 0.34% 24
2018
Q4
$1.18M Buy
9,102
+1,161
+15% +$162K 0.33% 25
2018
Q3
$1.1M Buy
7,941
+33
+0.4% +$4.38K 0.28% 29
2018
Q2
$960K Buy
7,908
+29
+0.4% +$3.62K 0.26% 28
2018
Q1
$1.01M Sell
7,879
-912
-10% -$123K 0.28% 28
2017
Q4
$1.23M Sell
8,791
-446
-5% -$62.1K 0.33% 27
2017
Q3
$1.2M Buy
9,237
+218
+2% +$28.9K 0.35% 23
2017
Q2
$1.19M Sell
9,019
-136
-1% -$17.3K 0.36% 24
2017
Q1
$1.14M Sell
9,155
-4
-0% -$478 0.37% 21
2016
Q4
$1.05M Buy
9,159
+307
+3% +$35.5K 0.36% 21
2016
Q3
$1.05M Buy
8,852
+41
+0.5% +$4.97K 0.36% 22
2016
Q2
$1.07M Buy
8,811
+441
+5% +$50.1K 0.38% 21
2016
Q1
$906K Buy
8,370
+140
+2% +$14.5K 0.33% 22
2015
Q4
$845K Buy
8,230
+312
+4% +$31.4K 0.32% 22
2015
Q3
$739K Buy
7,918
+73
+0.9% +$7.06K 0.3% 24
2015
Q2
$765K Buy
7,845
+26
+0.3% +$2.6K 0.29% 23
2015
Q1
$787K Buy
7,819
+2,523
+48% +$257K 0.3% 24
2014
Q4
$554K Buy
5,296
+22
+0.4% +$2.32K 0.22% 29
2014
Q3
$562K Buy
5,274
+355
+7% +$36.8K 0.23% 27
2014
Q2
$515K Buy
4,919
+23
+0.5% +$2.33K 0.21% 27
2014
Q1
$481K Sell
4,896
-760
-13% -$70.5K 0.2% 28
2013
Q4
$518K Sell
5,656
-48
-0.8% -$4.42K 0.22% 30
2013
Q3
$494K Buy
5,704
+759
+15% +$68.1K 0.22% 30
2013
Q2
$425K Buy
+4,945
New +$420K 0.2% 30

Other funds holding JNJ

Carlson Capital Management's JNJ Position: Q4 2024 in Review

Carlson Capital Management increased its Johnson & Johnson (JNJ) stake by 1.6% in Q4 2024, buying an estimated $8.52K and bringing the position to 3,494 shares worth $505K. The position accounts for 0.02% of the portfolio, ranked #76.

Carlson Capital Management first reported a position in JNJ in Q2 2013 and has held it in 47 quarters since. The position peaked at $2.89M in Q1 2022. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Carlson Capital Management held 3,494 shares of Johnson & Johnson worth $505K as of Q4 2024.
  • Carlson Capital Management bought 55 Johnson & Johnson shares in Q4 2024, an estimated $8.52K.
  • Johnson & Johnson made up 0.02% of Carlson Capital Management's portfolio in Q4 2024, its #76 holding.
  • Carlson Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 47 quarters since.
  • Carlson Capital Management's Johnson & Johnson position peaked at $2.89M in Q1 2022.
  • 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Carlson Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.